Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSCs for Ileal Pouch Fistulas in Crohn's Disease
NCT04073472Phase 1Withdrawn
- Sponsor
- Cleveland Clinic
- Start
- Jun 2021
- Primary completion
- Jun 2022
- Modality
- Stem Cell Therapies
01
Overview
Phase 1, open-label, single-arm trial of mesenchymal stem cells in Crohn's disease, sponsored by Cleveland Clinic. Primary endpoint: Number of Adverse Events at 12 months. Planned start Jun 2021; status: withdrawn.
02
Drugs
mesenchymal stem cells
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT04073472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04073472.